Azure Health Technology Limited (ASX: AZT) has announced that Mr Lou Panaccio has been appointed to the board as an independent non-executive Chairman and Dr Glenn Tong has been appointed to the board as a non-executive director.
These appointments are part of the process towards the acquisition of Invictus Biopharma Ltd. Once the acquisition of Invictus is complete, it is proposed that Dr Tong will be appointed as the Chief Executive Officer and Managing Director of the Company
Mr Panaccio possesses more than 30 years’ executive leadership experience in healthcare services and life sciences and Dr Tong has over 20 years of executive management and Board experience in rapid growth biotech companies.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.